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A 55-year-old male presented with Coombs’-positive hemolytic anemia of a hemoglobin level of 38 g/L, secondary to 
active pulmonary tuberculosis. The hemoglobin returned to 140 g/L and anti-complement antibody converted to neg-
ative after 5-month antituberculous therapy. The patient remained healthy after a total of 6 months of antituberculous 
therapy without steroid use.
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Introduction
Disseminated or miliary tuberculosis has commonly 
been associated with various hematological abnor-
malities.1 Most patients with pulmonary or dissem-
inated tuberculosis presented with minor degrees of 
anemia, but severe immune hemolytic anemia was 
extremely rare.2,3 We described an active tubercu-
lous pneumonia patient with a transient severe 
hemolytic anemia that showed good response to anti-
tuberculous medicines without steroid therapy.
Case Report
A 55-year-old man has a history of intermittent fever, 
severe dizziness and increasing shortness of breath 
on effort 1 week before presenting to our emergency 
department. He denied previous systemic disease. 
He had no prior hematological disorder or history of 
anemia and took no drugs.
On examination, the patient’s body temperature 
was 38ºC, pulse rate was 100 beats per minute and 
the respiratory rate was 20 breaths per minute. The 
patient’s blood pressure was 126/61 mmHg. The chest 
radiograph disclosed increased reticular infiltrates 
with multiple nodular lesions over the bilateral lung 
fields (Figure 1). Further computed tomogram of the 
chest scan showed multi-cluster of small nodules 
and cavitary lesions over the both lungs (Figure 2). 
Abdominal sonography revealed no obvious focal 
lesion and no hepatosplenomegaly. The stool guaiac 
test and pan-endoscopy showed negative findings. 
Initial laboratory data were as follows: hemoglobin, 
38 g/L; hematocrit, 0.125; mean corpuscular volume, 
128.9 fL; mean corpuscular hemoglobin, 39.2 pg/
cell; mean corpuscular hemoglobin concentration, 
304 g/L of red blood cells (RBC); reticulocyte count, 
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10.1%; haptoglobin, < 0.38 g/L; total leukocyte count, 
13.52 × 109/L (lymphocyte, 9%; segment, 89%; and 
monocyte, 2%); platelet count, 452 × 109/L; total bili-
rubin, 62 μmol/L; lactate dehydrogenase, 8.5 μkat/L; 
albumin, 30 g/L.
The serum levels of asparate aminotransferase, 
alanine aminotransferase, alkaline phosphatase, uric 
acid, urea nitrogen, calcium, creatinine, vitamine 
B12, folate, HbA1c, IgE, carcinoembryonic antigen, 
α-fetoprotein, rheumatoid factor, and glucose-6-
phosphate dehydrogenase were within normal limits. 
Serologic tests for antinuclear antibodies, HIV, and 
Cryptococcus antigen were negative. The positive 
Coombs’ test disclosed both anti-IgG and anti-C3 
antibodies. Periphery blood smear film for blood 
cells showed macrocytic normochromic anemia, 
normal platelets and normal leukocyte morphology 
with slight shift to left change. Hemoglobin elec-
trophoresis was within normal limits. Bone marrow 
aspiration specimens showed erythroid hyperpla-
sia. Hypercellular bone marrow with an increased 
amount of both erythoid and myeloid series was in 
bone marrow biopsy. There was no evidence of ma-
lignancy or caseous changes. Cultures from blood and 
urine specimens for mycobacterium and microbes 
revealed no grower. Acid-fast bacilli were found in 
the sputum.
He received isoniazid (300 mg per day), rifam-
picin (600 mg per day), ethambutol (800 mg per day), 
and pyrazinamide (500 mg, three times a day) on 
July 20, 2005, and rapidly became afebrile. 
Multiple blood transfusions were for initial severe 
anemia with hemoglobin of 38 g/L during first week 
of admission. The blood transfusion was done due 
to patient with severe symptoms and signs, including 
dizziness, weakness, short of breath and very low 
level of hemoglobin. In our patient, there were no 
transfusion-associated side effects or reactions 
Figure 1 Chest radiogram showing reticulonodular infil-
trates with multiple small nodules over the both lungs.
Figure 2 High resolution computed tomography of 
chest disclosing cavitary lesion over left upper lobe and 
reticulonodular opacities with tree-in-bud appearance 
over bilateral lung fields.
happening to him either during or following a blood 
transfusion. Culture of sputum grew Mycobacterium 
tuberculosis about 6 weeks later. The patient was 
well with stable hemoglobin level (about 140 g/L) and 
the chest films showed great improvement 5 months 
after antituberculous therapy. Simultaneously, the 
Coombs’ test was still positive, but the anti-C3 anti-
body was converted to negative despite positive 
the anti-IgG antibody. He had taken antituberculous 
medicines without steroid supplement for 6 months. 
He has remained healthy without symptoms or signs 
of hemolytic anemia till now (see Table 1 for serial 
laboratory data).
Discussion
The possible mechanism for the development of 
anemia in mycobacterium infection may be due to 
nutritional insufficiency, impaired iron utilization, 
malabsorption syndrome, bone marrow granuloma 
and shortened duration of RBC survival.4 Autoimmune 
hemolytic anemia may occur following a wide variety 
of infections4,5 with a positive Coombs’ test. A special 
variety of visceral tuberculosis, involving the re-
ticuloendothelial system, can occasionally lead to 
blood disorders through immune mechanisms.6 Our 
patient showed that isolated active pulmonary tu-
berculosis can result in severe immune hemolytic 
anemia. To our knowledge, in previous reports,2,3,6−11 
most cases of hemolytic anemia were secondary to 
disseminated tuberculosis. Only 3 of the 11 cases 
were associated with pulmonary tuberculosis.6−8 
However, immune hemolytic anemia resulting in a 
hemoglobin level of 38 g/L, as occurred in our patient 
who has a good response to 6-month antituberculous 
without steroid use, is very rare. For infection-
associated hemolytic anemia, such as pulmonary 
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tuberculosis, immediate initiation of effective 
antimicrobial is critical. Although tuberculosis can 
induce hemolytic anemia, the mechanism is unclear. 
A number of experimental studies have indicated 
that tuberculosis may induce the development of 
widespread abnormalities in the hematopoietic 
tissues. In animals, injection of tubercle bacilli or 
their products induced hemolytic anemia. In human, 
the acid fast bacilli may provoke a marked prolif-
eration of reticuloendothelial tissues resulting in 
myeloproliferative syndromes. In our case, bone 
marrow examination revealed erythroid hyperplasia, 
similar to the previous reported cases, which tuber-
culosis associated the blood disease was postulated. 
The possibility is favored by a number of observa-
tions antecedent, active tuberculosis in many of 
the patients with coexisting tuberculosis and blood 
disease; the failure to find leukemic lesions at au-
topsy in patients with tuberculosis and leukemia and 
the experimental animal studies which demon-
strated altered growth pattern in cells and tissues 
caused by tubercle bacilli or their products.
The inadvertent use of steroid or even splenec-
tomy9 for untreated or undiagnosed tuberculosis 
with immune hemolytic anemia can induce exacer-
bated consequence. Diagnosis of pulmonary tuber-
culosis was established by identification of acid-fast 
bacilli and mycobacterium growth from sputum. 
After antituberculous therapy, hematological nor-
malization is an important proof that tuberculosis 
is the underlying cause of hemolytic anemia. Our 
patient received antituberculous drugs including 
isoniazid, rifampicin, pyranizamide, and ethambutol, 
but no drug-induced hemolytic side effects were 
observed. Another interesting issue is that patient 
had a stable hemoglobin level and no clinical symp-
toms or signs of hemolytic anemia despite persis-
tent positive Coombs’ test. Both tuberculosis process 
and multiple blood transfusions could result in pos-
itive Coombs’ test. The continuous positive Coombs’ 
test after antituberculous therapy might be associ-
ated with a previous blood transfusion rather than 
tuberculosis because of the negative conversion of 
sputum 2 months later. Furthermore, 5 months after 
antituberculous therapy, the anti-C3 antibody dis-
appeared. The coexistence of C3 and IgG behaves in 
a synergistic way, leading to a more severe hemo-
lytic anemia.12 There are three basic mechanisms 
by which infections may result in hemolysis on an 
immune basis: antibodies to the RBCs are produced 
as a result of the infection; antibody-antigen com-
plexes specially related the infectious agent coat 
the RBCs and the infectious agent results in exposure 
of RBC antigens to naturally occurring antibodies. 
The complement C3 may allow the RBCs to become 
attached, via C3b receptors, to a phagocyte, as oc-
curred in the case here. The complement (C3) may T
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play a contributing role in tuberculosis-associated 
hemolytic anemia involving immune-complex-
complement process.
Active pulmonary tuberculosis, as well as dis-
seminated tuberculosis, can cause severe autoim-
mune hemolytic anemia. A delay in the diagnosis of 
tuberculosis with severe anemic patients could be 
life-threatening. Thus, effective 6-month antitu-
berculous regimens without steroid are sufficient 
to treat tuberculosis-induced hemolytic anemia. 
The connection of negative conversion of anti-
complement (anti-C3) antibody to recovery of 
hemolytic anemia in tuberculosis patients may be 
important and deserves to be investigated further.
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